Provides guidance on utilizing the Framingham Heart Study charts for primary prevention and risk estimation of coronary heart disease.
This statement discusses the new Framingham Heart Study charts for estimating (CHD) coronary heart disease risk, their essential features, and their appropriate use. In addition, several issues related to CHD prevention raised by these charts are examined. Other issues of risk management not considered in these charts are also addressed.
Grundy et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: